
Developer of Extracorporeal Artificial Heart Devices


The 4th Annual Zheoyao Thermal Power List
As an authoritative barometer in the new economy and venture capital investment field, the "Sparkling Heat Power List" focuses on high-quality enterprises in high-growth tracks. It evaluates companies based on four core criteria: technological leadership, industrial influence, market growth potential, and sustainable development capabilities. After multiple rounds of rigorous screening, professional evaluations by industry experts, and joint recommendations from investment institutions, the final selection highlights outstanding enterprises with strong development potential and the ability to lead industry innovation. The list's authority and industry recognition are highly regarded. This year’s list places significant emphasis on core sectors such as medical devices and life health. The emergence of magAssist signifies not only the company’s innovative strength...This is a high recognition of strength, as well as strong evidence of the achievements in the independent research and development of domestically produced life support equipment in China.
Looking back at 2025, the new economy sector showed a thriving trend, with capital markets continuously tilting towards high-value innovation fields. Among these, the medical device and life health sectors became the core focus of industrial upgrading.CIC灼识咨询, as an authoritative institution in the industry, has released the "灼耀热力榜" for four consecutive years, deeply connecting capital, industry, and innovation resources to help high-quality enterprises achieve leapfrog development. magAssist's inclusion in this list fully recognizes its innovative strength and industry influence in the life support field.

As an internationally recognized frontier enterprise in the MCS (Mechanical Circulatory Support) field, magAssist consistently adheres to its core mission of "Technology Protecting Life," focusing on the research, development, production, and clinical application of mechanical circulatory support devices. It has built a comprehensive, full-scenario life support product portfolio, including the extracorporeal fully magnetically levitated artificial heart (MoyoAssist®), ECMO (BreathMo®)【1】, and interventional artificial heart (NyokAssist®)【1】, achieving a critical leap from single-point technological innovation to platform-based development.
Technological innovation is the core competitiveness of magAssist. The company focuses on key core technologies such as mechatronics and full magnetic levitation control, with over 400 patent applications accumulated. In terms of clinical implementation, magAssist's products have been widely used in various severe heart failure cases and complex surgical scenarios, providing patients with stable circulatory support. Relevant clinical outcomes have gained high recognition within the industry.
This time, winning the "Radiant Star" honor is not only an authoritative endorsement of magAssist's innovative strength and clinical value but also a strong push for the development of life-support devices produced in China. In the future, magAssist will take this award as a new starting point, continue to deepen its expertise in the life-support field, strengthen technological breakthroughs and product iterations, and promote more Chinese medical devices to reach clinical settings and go global. By doing so, magAssist aims to make self-innovated life-support solutions benefit more patients, safeguard every glimmer of life with technological power, and demonstrate the responsibility and commitment of Chinese medical device companies.
[1] This product information is for research and exchange only, has not been approved by the National Medical Products Administration (NMPA), and has not been sold in any country or region.
-END-
